Tags » Tocilizumab

Stopping DMARDs Often Unnecessary for RA Patients Prior to Orthopaedic Surgery

Most patients with rheumatoid arthritis (RA) will undergo orthopaedic surgery during the course of their disease, and more than 80% of that cohort will be taking traditional or biologic disease-modifying antirheumatic drugs (DMARDs) at the time of their operations. 170 more words

Surgeon Edition

Turbo charge day

I’m not sure how many of you know what it is like to have a chronic disease – what it means to me is a way of life! 731 more words

Tocilizumab is well tolerated in elderly rheumatoid arthritis patients but shows lower efficacy

A relatively new biologic treatment that is approved for treating rheumatoid arthritis is Tocilizumab (trade name Actemra and RoActemra). Tocilizumab is a humanised monoclonal antibody that targets interleukin-6 receptor (IL-6R), thus blocking interleukin-6 (IL-6) cytokine mediated signalling, which is known to play an important role in mediating inflammatory processes. 242 more words

Treatment